Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Conatus Pharmaceuticals Inc (NASDAQ:CNAT)

1.90
BATS BZX Real-Time Price
As of 1:36pm ET
 -0.10 / -5.00%
Today’s Change
1.40
Today|||52-Week Range
7.12
-34.03%
Year-to-Date

Today’s Trading

Previous close2.00
Today’s open2.02
Day’s range1.77 - 2.09
Volume44,100
Average volume (3 months)159,414
Market cap$44.2M
Dividend yield--
Data as of 1:36pm ET, 08/30/2016

Growth & Valuation

Earnings growth (last year)+9.72%
Earnings growth (this year)-3.33%
Earnings growth (next 5 years)+74.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.15

Competitors

 Today’s
change
Today’s
% change
GLMDGalmed Pharmaceutica...+0.01+0.25%
AMPEAmpio Pharmaceutical...0.000.00%
IPCIIntellipharmaceutics...0.000.00%
MTEXMannatech Inc-0.22-1.31%
Data as of 1:40pm ET, 08/30/2016

Financials

Next reporting dateNovember 9, 2016
EPS forecast (this quarter)-$0.34
Annual revenue (last year)$0.00
Annual profit (last year)-$24.1M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Steven J. Mento
Chief Financial Officer, Secretary &
SVP-Finance
Charles J. Cashion
Corporate headquarters
San Diego, California

Forecasts

Search for Jobs